Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp Regulatory News (PEYS)

Share Price Information for Partners Grp (PEYS)

Share Price is delayed by 15 minutes
Get Live Data
602.00    -11.00 (-1.79%)
Bid:
598.00
Ask:
614.00
Spread: 16.00 (2.676%)
Market Cap: £404.29m
PEYS Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp Share Chart

PGPE Ltd publishes May NAV

28 Jun 2024 07:00

RNS Number : 2418U
Partners Group Private Equity Ltd
28 June 2024
 

(LSE: PEYS/PEY)

 

Partners Group Private Equity Limited

 

PGPE Ltd publishes May NAV

 

 

· NAV decreased by 0.7% to EUR 14.19 per share; total net assets at EUR 981.43 million

· PGPE Ltd declared a first interim dividend of EUR 0.355 per share, with the shares trading ex-dividend during the month

· Value creation contributed 0.2%, while currency movements detracted 0.7%

· PGPE Ltd received distributions of EUR 22.9 million and invested EUR 1.0 million

 

In May, the Company received distributions of EUR 22.9 million, largely from the sale of Civica, a UK-based provider of cloud software solutions for the public sector. Since Partners Group's initial investment on behalf of its clients in 2017, Civica has grown into a global leader in this space. Civica's software is used by over 6'200 public sector customers for the running of essential government functions across four verticals, including local government, healthcare, education, and central government, enabling improved delivery of services to citizens while reducing costs and boosting revenue and productivity.

 

EUR 0.6 million stemmed from the partial sale of PGPE Ltd's interest in Galderma, a global dermatology company that develops, manufactures, and distributes a range of medical and consumer skin health solutions. In March 2024, Galderma raised USD 2.6 billion via a public listing on the SIX Swiss Exchange, with the proceeds from the share sale being used primarily to pay down debt and refinance the remaining capital structure. Headquartered in Switzerland, the company has a global presence in over 50 locations across 40 countries. 

 

The resolution to change the Company's name to Partners Group Private Equity Limited passed its shareholder vote at the Annual General Meeting which was held after month end. To reflect the Company's new name, the corporate website address will be changed to www.partnersgroupprivateequitylimited.com. Shareholders should take note that temporarily, the old website would still be accessible. All other Company details including the ISIN, SEDOL and TIDM will remain unchanged. Shareholders are unaffected by the changes and existing share certificates will remain valid and should be retained. 

 

 

Further information is available in the monthly report, which can be accessed via:

https://www.partnersgroupprivateequitylimited.com/en/investor-relations/financial-reports/

 

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd (formerly Princess Private Equity Holding Limited) is an investment holding company founded in 1999 and domiciled in Guernsey. It invests in private equity direct investments. PGPE Ltd is managed in its investment activities by Partners Group, a global private markets investment management firm with USD 147 billion in investment programs under management in private markets, of which USD 76 billion is in private equity. PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield. PGPE Ltd is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

Investor relations contact:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

Media relations contact:

Jenny Blinch

Phone: +41 41 784 65 26

E-mail: jenny.blinch@partnersgroup.com

 

Registered Number: 35241 LEI: 54930038LU8RDPFFVJ57

Notes:

1. Note that references in this announcement to Partners Group Private Equity Limited have been abbreviated to "PGPE Ltd" or "Company". References to Partners Group AG have been abbreviated to "Partners Group" or "Investment Manager".

2. This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Partners Group Private Equity Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

3. This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of PGPE Ltd's website nor the contents of any website accessible from hyperlinks on PGPE Ltd's website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDLGGDDGSR
Date   Source Headline
4th Dec 20247:00 amRNSNAV increases by 2.4% in October
21st Nov 20247:22 amRNSResults presentation webcast details
5th Nov 20247:00 amRNSSave the date for Q3 2024 results announcement
4th Nov 20247:00 amRNSNAV increases by 0.5% in September
28th Oct 20247:00 amRNSDirector/PDMR Shareholding
23rd Oct 202410:00 amRNSDividend Declaration
10th Oct 20247:15 amRNSPortfolio company prices IPO and lists on NYSE
4th Oct 20247:00 amRNSPGPE Ltd publishes August NAV
1st Oct 20247:15 amRNSSale of Techem
4th Sep 20247:00 amRNSPGPE Ltd publishes July NAV
22nd Aug 20247:00 amRNSPGPE Ltd publishes Half-Year Report 2024
2nd Aug 20247:00 amRNSNAV increases by 1.3% in June
1st Aug 20247:00 amRNSSave the date for H1 2024 results announcement
1st Jul 20247:00 amRNSTotal Voting Rights
28th Jun 20247:00 amRNSPGPE Ltd publishes May NAV
25th Jun 20247:00 amRNSConfirmation of Change of Name
21st Jun 20241:00 pmRNSResults of AGM and Change of Name
4th Jun 20247:00 amRNSPrincess publishes April NAV
3rd Jun 20247:00 amRNSTotal Voting Rights
28th May 20247:00 amRNSPrincess Q1 2024 results presentation
9th May 20247:00 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSDividend Declaration
7th May 20247:00 amRNSNAV increases by 3.6% in March
7th May 20247:00 amRNSSave the date for Q1 2024 results announcement
1st May 20247:00 amRNSTotal Voting Rights
24th Apr 20247:00 amRNSNotice of Annual General Meeting
8th Apr 20244:35 pmRNSPrincess publishes February NAV
2nd Apr 20245:15 pmRNSSale of SRS Distribution
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSPrincess 2023 annual results and webcast details
21st Mar 20243:17 pmRNSChanges to Board Composition
4th Mar 20247:00 amRNSNAV increases by 0.8% in January
15th Feb 20247:00 amRNSChanges to Board composition
5th Feb 20247:00 amRNSPrincess publishes December NAV
5th Feb 20247:00 amRNSSave the date for 2023 annual results announcement
1st Feb 20247:00 amRNSTotal Voting Rights
5th Jan 20247:00 amRNSPrincess publishes November NAV
2nd Jan 20247:00 amRNSTotal Voting Rights
8th Dec 20233:00 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSPrincess publishes October NAV
24th Nov 20232:05 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSPrincess Q3 2023 Updates
22nd Nov 202311:30 amRNSSale of Civica
1st Nov 20237:00 amRNSNAV increases by 0.9% in September
1st Nov 20237:00 amRNSTotal Voting Rights
30th Oct 20237:00 amRNSChanges to Board Composition
27th Oct 20235:30 pmRNSDividend Declaration
23rd Oct 20237:00 amRNSSave the date for Q3 2023 results announcement
2nd Oct 20237:00 amRNSNAV increases by 0.6% in August

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.